Vardenafil (Levitra) has a smaller share of the market behind Viagra and Cialis, haven't looked into the reason why but the whole sector is on the increase. Currently they are all administered orally with the downsides mentioned previously so a new delivery method might really shake things up.
The global erectile dysfunction drugs market size was valued at USD 2.46 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 8.8% from 2023 to 2030. There is a growing demand for erectile dysfunction (ED) drugs owing to the adoption of a sedentary lifestyle, associated stress, the increasing geriatric population, and the correlation between erectile dysfunction and diabetes, heart disease, and other chronic conditions. According to the Clinical Epidemiology and Global Health Journal, ED affects more than 150 million men globally, and by 2025, that number is predicted to rise to 322 million. The primary risk factor for the onset of ED is type 2 diabetes mellitus (T2DM), and diabetic men are three times more likely to develop ED than men without the disease.
LTP Price at posting:
35.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)